CELV (Cellev8 Nutrition) Debt-to-EBITDA : (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CELV Cellev8 Nutrition Inc CELV
30 GF Score
Price $0.09
View Full Analysis

What is Cellev8 Nutrition Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Cellev8 Nutrition's Short-Term Debt & Capital Lease Obligation for the quarter that ended in May. 2026 was $14.14 Mil. Cellev8 Nutrition's Long-Term Debt & Capital Lease Obligation for the quarter that ended in May. 2026 was $0.00 Mil. Cellev8 Nutrition's annualized EBITDA for the quarter that ended in May. 2026 was $-1.37 Mil. Cellev8 Nutrition's annualized Debt-to-EBITDA for the quarter that ended in May. 2026 was -10.36.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Cellev8 Nutrition's Debt-to-EBITDA or its related term are showing as below:

CELV's Debt-to-EBITDA is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 2.115
* Ranked among companies with meaningful Debt-to-EBITDA only.

Cellev8 Nutrition  (OTCPK:CELV) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Cellev8 Nutrition Debt-to-EBITDA Related Terms


Cellev8 Nutrition Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Cellev8 Nutrition's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cellev8 Nutrition Debt-to-EBITDA Chart

Cellev8 Nutrition Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cellev8 Nutrition Quarterly Data
May21 Aug21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CELV vs LFVN, MAMA, NATR: Debt-to-EBITDA Comparison

For the Packaged Foods subindustry, Cellev8 Nutrition's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cellev8 Nutrition Debt-to-EBITDA vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Cellev8 Nutrition's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cellev8 Nutrition's Debt-to-EBITDA falls into.


CELV
30GF Score
Cellev8 Nutrition Inc CELV
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cellev8 Nutrition Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Cellev8 Nutrition's Debt-to-EBITDA for the fiscal year that ended in Nov. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.530972 + 0) / -1.495456
=-1.02

Cellev8 Nutrition's annualized Debt-to-EBITDA for the quarter that ended in May. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(14.139542 + 0) / -1.365312
=-10.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (May. 2026) EBITDA data.


Cellev8 Nutrition Business Description

Address 3361 Fairline Farms Road, Unit No. 3, Wellington, FL, USA, 33414
Cellev8 Nutrition Inc is engaged in the development, markets, and sells a line of proprietary blended cellular therapeutics named Cellev8. Its products are based on formulations containing Superoxide Dismutase (SOD) and are developed for health-related applications.
30GF Score

Get the complete analysis for CELV

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.09
Price